ANDA 040832

NOVAST LABS

FDA Drug Application

Application #040832

Application Sponsors

ANDA 040832

NOVAST LABS

Marketing Status

• Prescription: 001

Application Products

001

TABLET;ORAL

325MG;200MG

0

CARISOPRODOL AND ASPIRIN

ASPIRIN; CARISOPRODOL

FDA Submissions

ORIG

1

AP

2010-01-07

Submissions Property Types

ORIG

1

Null

7

TE Codes

001

Prescription

AB

CDER Filings

NOVAST LABS

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 40832
            [companyName] => NOVAST LABS
            [docInserts] => ["",""]
            [products] => [{"drugName":"CARISOPRODOL AND ASPIRIN","activeIngredients":"ASPIRIN; CARISOPRODOL","strength":"325MG;200MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"CARISOPRODOL AND ASPIRIN","submission":"ASPIRIN; CARISOPRODOL","actionType":"325MG;200MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)